DJIA 17,971.94 -62.99 -0.35%
NASDAQ 5,011.76 17.16 0.34%
S&P 500 2,099.91 -0.49 -0.02%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

32.37 -1.90 (-5.54%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYGN $32.37 -5.54%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.10
Previous Close $34.27
Daily Range $32.08 - $34.73
52-Week Range $31.56 - $42.50
Market Cap $2.3B
P/E Ratio 23.63
Dividend (Yield) $0.00 (0.0%)
Volume 687,613
Average Daily Volume 679,870
Current FY EPS $1.53




Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website:

News & Commentary Rss Feed

3 Megatrends in Healthcare

These three megatrends could be largely responsible for value creation and the impetus for innovation within the healthcare sector throughout the remainder of the decade.

A Possible Glimpse Into the Future: Is a $1 Prostate Cancer Test on the Way?

A more accurate and significantly cheaper prostate cancer screening test? Find out what researchers at the University of Central Florida are up to -- and how it could transform prostate cancer diagnoses many years down the road.

Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates

Myriad Genetics (MYGN) Shares Cross Above 200 DMA

MYGN May 22nd Options Begin Trading

Top 4 Stocks In The Research Services Industry With The Highest Revenue

Myriad's Downside Case Might Not Matter

Myriad Genetics: Issues Are Compounding But Long-Term Drivers Still Intact

Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere

Has Quest Diagnostics Rediscovered Its Touch?

See More MYGN News...

MYGN's Top Competitors

MYGN $32.37 (-5.54%)
Current stock: MYGN
AMGN $167.97 (1.21%)
Current stock: AMGN
GILD $104.41 (3.73%)
Current stock: GILD
BIIB $423.30 (0.09%)
Current stock: BIIB